Allspring Global Investments Reduces Stake in Bio-Rad Laboratories

Institutional investor trims position in medical research company

Apr. 3, 2026 at 7:05am

Got story updates? Submit your updates here. ›

An extreme close-up of the intricate, metal components and gears of a high-tech medical laboratory instrument, conveying the complex, industrial nature of Bio-Rad Laboratories' specialized equipment.An institutional investor's reduced stake in Bio-Rad Laboratories reflects broader shifts in the medical research equipment market.Hercules Today

Allspring Global Investments Holdings LLC, a major institutional investor, reduced its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) by 4.1% in the fourth quarter, according to a recent SEC filing. The firm now owns 129,211 shares of the medical research company's stock, valued at $39.4 million.

Why it matters

This filing provides insight into the investment decisions of a prominent institutional investor and could signal broader market sentiment around Bio-Rad Laboratories. Tracking changes in institutional ownership is an important indicator for analyzing the health and outlook of publicly traded companies.

The details

According to the SEC filing, Allspring Global Investments sold 5,556 shares of Bio-Rad Laboratories during the fourth quarter, reducing its total position to 129,211 shares. The firm previously owned 0.48% of Bio-Rad's outstanding shares. Bio-Rad is a leading provider of life science research and clinical diagnostic products, operating in the Life Science and Clinical Diagnostics segments.

  • The filing covers the fourth quarter of 2025.
  • Allspring Global Investments made the changes to its Bio-Rad Laboratories position during this period.

The players

Allspring Global Investments Holdings LLC

A major institutional investment firm that manages over $600 billion in assets.

Bio-Rad Laboratories, Inc.

A global provider of life science research and clinical diagnostic products, headquartered in Hercules, California.

Got photos? Submit your photos here. ›

The takeaway

This filing highlights the ongoing shifts in institutional ownership of Bio-Rad Laboratories, a prominent medical research company. Tracking changes in major investors' positions can provide valuable insights into the market's sentiment and outlook for the stock.